[Today’s] news marks a critical moment for people who were concerned about getting vaccinated due to the vaccines being authorized for emergency use. With millions of data points on the vaccine’s safety and efficacy over nearly nine months of vaccinations, every ‘i’ is dotted and every ‘t’ is crossed. — American Medical Association, American Hospital Association and American Nurses Association
[Today’s] news marks a critical moment for people who were concerned about getting vaccinated due to the vaccines being authorized for emergency use. With millions of data points on the vaccine’s safety and efficacy over nearly nine months of vaccinations, every ‘i’ is dotted and every ‘t’ is crossed. — American Medical Association, American Hospital Association and American Nurses Association
Vaccine Mandates Move Ahead After F.D.A. Approval of Pfizer Shot
Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school districts to announce vaccine mandates for their employees.

National medical groups hailed the step. A joint statement by the American Medical Association, American Hospital Association and American Nurses Association called it “a major step forward in the worldwide effort to end this pandemic.”

“Today’s news marks a critical moment for people who were concerned about getting vaccinated due to the vaccines being authorized for emergency use,” the statement said. “With millions of data points on the vaccine’s safety and efficacy over nearly nine months of vaccinations, every ‘i’ is dotted and every ‘t’ is crossed.”

The groups added, “With the Delta variant surging, there has never been a better time to get vaccinated.”


... Before the F.D.A.’s announcement, the three coronavirus vaccines available in the United States, made by Pfizer-BioNTech, Moderna and Johnson & Johnson, were all being administered in the United States under an emergency use authorization. (The Pfizer vaccine remains available on that basis for youths 12 to 15 and for extra doses for some immunocompromised people.)

The F.D.A.’s approval action on Monday could reinforce the legal standing of some mandates and pave the way for some organizations to impose stricter requirements and no longer allow employees the option of frequent testing as an alternative to getting vaccinated.

Officials also hope that full federal approval will quiet some of the vaccine misinformation online and induce more hesitant people to get vaccinated. A recent poll by the Kaiser Family Foundation found that three out of every 10 unvaccinated people said that they would be more likely to get a shot once it was fully approved.

Dr. Ashish K. Jha, dean of Brown University’s School of Public Health, wrote on Twitter on Monday that he thought full approval of the vaccine would make a difference, “mostly by providing confidence to businesses, schools, and yes, our military to mandate vaccines. And it is already starting to happen.”
Read the full article: https://www.nytimes.com/2021/08/23/us/fda-approves-pfizer-vaccine.html